.png){kind=icon}
返回
AI-driven transcriptome profile-guided hit molecule generation
.png){kind=icon}
OA
AI
DOI：10.1016/j.artint.2024.104239.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
De novo generation of bioactive and drug-like hit molecules is a pivotal goal in computer- aided drug discovery. While artificial intelligence (AI) has proven adept at generating molecules with desired chemical properties, previous studies often overlook the influence of disease- specific cellular environments. This study introduces GxVAEs, a novel AI-driven deep generative model designed to produce hit molecules from transcriptome profiles using dual variational autoencoders (VAEs). The first VAE, ProfileVAE, extracts latent features from transcriptome profiles to guide the second VAE, MolVAE, in generating hit molecules. GxVAEs aim to bridge the gap between molecule generation and the biological context of disease, producing molecules that are biologically relevant within specific cellular environments or pathological conditions. Experimental results and case studies focused on hit molecule generation demonstrate that GxVAEs surpass current state-of-the-art methods, in terms of reproducibility of known ligands. This approach is expected to effectively find potential molecular structures with bioactivities across diverse disease contexts.
Keyword:
Transcriptome profiles
Hit molecule generation
Dual VAEs
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
13.9
论文数:
6.1K
被引数:
1.9W
机构
引用论文
EarlGAN: An enhanced actor-critic reinforcement learning agent-driven GAN for de novo drug designEarlGAN: 一种用于从头药物设计的增强型演员-批评家强化学习代理驱动的GAN
PREAI
分享收藏SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules微笑，一种化学语言和信息系统。1.介绍方法和编码规则
PREAI
分享收藏LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures.png)
NUCLEIC ACIDS RESEARCHOAAI
NUCLEIC ACIDS RESEARCHIF13.1
OAAI分享收藏A guide for bioinformaticians: 'omics-based drug discovery for precision oncologyDRUG DISCOVERY TODAY
DRUG DISCOVERY TODAYIF7.5
PREAI
分享收藏
查看更多内容